كندا - الإنجليزية - Health Canada

alk-abello inc - standardized meadow fescue grass pollen - liquid - 100000unit - standardized meadow fescue grass pollen 100000unit - allergenic extracts

كندا - الإنجليزية - Health Canada

alk-abello inc - standardized timothy grass pollen; standardized orchard grass pollen; standardized kentucky blue/june grass pollen; standardized redtop grass pollen - liquid - 25000unit; 25000unit; 25000unit; 25000unit - standardized timothy grass pollen 25000unit; standardized orchard grass pollen 25000unit; standardized kentucky blue/june grass pollen 25000unit; standardized redtop grass pollen 25000unit - allergenic extracts

كندا - الإنجليزية - Health Canada

alk-abello inc - standardized timothy grass pollen; standardized orchard grass pollen; standardized kentucky blue/june grass pollen; standardized redtop grass pollen; standardized sweet vernal grass pollen - liquid - 20000unit; 20000unit; 20000unit; 20000unit; 20000unit - standardized timothy grass pollen 20000unit; standardized orchard grass pollen 20000unit; standardized kentucky blue/june grass pollen 20000unit; standardized redtop grass pollen 20000unit; standardized sweet vernal grass pollen 20000unit - allergenic extracts

كندا - الإنجليزية - Health Canada

greer laboratories inc - non pollen - liquid - 40000unit - non pollen 40000unit - allergenic extracts

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

allermed laboratories, inc. - cotton seed (unii: di0zrj0mxn) (cotton seed - unii:di0zrj0mxn) - alnus rhombifolia pollen 0.05 g in 1 ml - allergenic extract may be used as a diagnostic skin test reagent in persons suspected of being sensitive to the allergenic source material from which the extract is made. skin tests should be used in conjunction with a thorough allergic history to establish the relevance of a given allergen in the etiology of allergic disease. 4,5,6 immunotherapy with allergenic extract is indicated in persons suffering from allergic rhinitis, bronchitis, conjunctivitis, urticaria and asthma. the therapeutic efficacy of allergenic extract has been proven in ragweed, grass, and mountain cedar pollinosis, cat-induced asthma and hypersensitivity to hymenoptera venoms. 7-12 immunotherapy may be used along with or exclusive of antihistamines and other medications used to control allergic symptoms. allergenic extract should not be administered to a non-allergic person. however, there are no absolute contraindications to the use of allergenic extract for treatment in appropriate individuals. relativ

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - dermatophagoides farinae allergen extract 50 ir ((american house dust mite)); dermatophagoides pteronyssinus allergen extract 50 ir ((european house dust mite)); dermatophagoides farinae allergen extract 150 ir ((american house dust mite)); dermatophagoides pteronyssinus allergen extract 150 ir ((dermatophagoides pteronyssinus)) - sublingual tablet - 100ir & 300ir - active: dermatophagoides farinae allergen extract 50 ir ((american house dust mite)) dermatophagoides pteronyssinus allergen extract 50 ir ((european house dust mite)) excipient: colloidal silicon dioxide croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose active: dermatophagoides farinae allergen extract 150 ir ((american house dust mite)) dermatophagoides pteronyssinus allergen extract 150 ir ((dermatophagoides pteronyssinus)) excipient: colloidal silicon dioxide croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose - actair is indicated for the treatment of house dust mite allergic rhinitis with or without conjunctivitis in adults, adolescents and children 5 years and over diagnosed with house dust mite allergy.

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

nelco laboratories, inc. - taraxacum officinale pollen (unii: wq3s5294xy) (taraxacum officinale pollen - unii:wq3s5294xy) - allergenic extracts are indicated for use in diagnostic testing and as part of a treatment regime for allergic disease, as established by allergy history and skin test reactivity. allergenic extracts are indicated for the treatment of allergen specific allergic disease for use as hyposensitization or immunotherapy when avoidance of specific allergens can not be attained. the use of allergenic extracts for therapeutic purpose has been established by well-controlled clinical studies. allergenic extracts may be used as adjunctive therapy along with pharmacotherapy which includes antihistamines, corticosteroids, and cromoglycate, and avoidance measures. allergenic extracts for therapeutic use should be given using only the allergen selection to which the patient is allergic, has a history of exposure and are likely to be exposed to again. allergenic extracts should not be used if the patient has asthma, cardiovascular disease, emphysema, diabetes, bleeding diathesis or pregnancy, unless a specific diagnosis of t

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

nelco laboratories, inc. - taraxacum officinale pollen (unii: wq3s5294xy) (taraxacum officinale pollen - unii:wq3s5294xy) - allergenic extracts are indicated for use in diagnostic testing and as part of a treatment regime for allergic disease, as established by allergy history and skin test reactivity. allergenic extracts are indicated for the treatment of allergen specific allergic disease for use as hyposensitization or immunotherapy when avoidance of specific allergens can not be attained. the use of allergenic extracts for therapeutic purpose has been established by well-controlled clinical studies. allergenic extracts may be used as adjunctive therapy along with pharmacotherapy which includes antihistamines, corticosteroids, and cromoglycate, and avoidance measures. allergenic extracts for therapeutic use should be given using only the allergen selection to which the patient is allergic, has a history of exposure and are likely to be exposed to again. allergenic extracts should not be used if the patient has asthma, cardiovascular disease, emphysema, diabetes, bleeding diathesis or pregnancy, unless a specific diagnosis of t

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

nelco laboratories, inc. - taraxacum officinale pollen (unii: wq3s5294xy) (taraxacum officinale pollen - unii:wq3s5294xy) - allergenic extracts are indicated for use in diagnostic testing and as part of a treatment regime for allergic disease, as established by allergy history and skin test reactivity. allergenic extracts are indicated for the treatment of allergen specific allergic disease for use as hyposensitization or immunotherapy when avoidance of specific allergens can not be attained. the use of allergenic extracts for therapeutic purpose has been established by well-controlled clinical studies. allergenic extracts may be used as adjunctive therapy along with pharmacotherapy which includes antihistamines, corticosteroids, and cromoglycate, and avoidance measures. allergenic extracts for therapeutic use should be given using only the allergen selection to which the patient is allergic, has a history of exposure and are likely to be exposed to again. allergenic extracts should not be used if the patient has asthma, cardiovascular disease, emphysema, diabetes, bleeding diathesis or pregnancy, unless a specific diagnosis of t

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

nelco laboratories, inc. - taraxacum officinale pollen (unii: wq3s5294xy) (taraxacum officinale pollen - unii:wq3s5294xy) - allergenic extracts are indicated for use in diagnostic testing and as part of a treatment regime for allergic disease, as established by allergy history and skin test reactivity. allergenic extracts are indicated for the treatment of allergen specific allergic disease for use as hyposensitization or immunotherapy when avoidance of specific allergens can not be attained. the use of allergenic extracts for therapeutic purpose has been established by well-controlled clinical studies. allergenic extracts may be used as adjunctive therapy along with pharmacotherapy which includes antihistamines, corticosteroids, and cromoglycate, and avoidance measures. allergenic extracts for therapeutic use should be given using only the allergen selection to which the patient is allergic, has a history of exposure and are likely to be exposed to again. allergenic extracts should not be used if the patient has asthma, cardiovascular disease, emphysema, diabetes, bleeding diathesis or pregnancy, unless a specific diagnosis of t